Sarepta already have US$1.6bn in the bank so the closing date of the raising is irrelevant.
Sarepta also have a potential US$1.7bn in milestone payments from Roche if they get the gene therapy approved.. paying ANP a sizeable license fee to help increase the chances of those funds being received seems like good business sense don’t you!!
Also, @waynesworld, delving further into Thrombospodin 1 has got me thinking alot longer term about my investment in ANP. No wonder Graham Mitchell mentioned “assured success”.
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-795
-
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Is oil undervalued?
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.4¢ |
Change
-0.003(4.48%) |
Mkt cap ! $57.69M |
Open | High | Low | Value | Volume |
6.5¢ | 6.5¢ | 6.3¢ | $25.49K | 393.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 28095 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.6¢ | 80417 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 28095 | 0.063 |
1 | 10000 | 0.062 |
2 | 60000 | 0.061 |
9 | 258455 | 0.060 |
2 | 10500 | 0.059 |
Price($) | Vol. | No. |
---|---|---|
0.066 | 80417 | 2 |
0.067 | 30074 | 1 |
0.070 | 35754 | 1 |
0.073 | 78000 | 1 |
0.075 | 13371 | 1 |
Last trade - 10.39am 06/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |